Latest Health News
Most Countries Progress Toward Universal Health Coverage, Challenges Remain
A WHO–World Bank report highlights that while most countries have made progress toward universal health coverage, significant gaps and challenges persist. Efforts include regional emergency preparedness and addressing issues like alcohol harms and female genital mutilation in Asia-Pacific.
Breakthrough in Cell Rejuvenation Offers Anti-Aging with Reduced Cancer Risks
A December 2025 Cell journal study reports partial epigenetic reprogramming in mice that rejuvenates cells and improves tissue repair, potentially extending healthy lifespan. This method selectively alters epigenetic markers without promoting cancer, with virtual cell models accelerating therapy development.
Global Financing Facility Receives $100 Million Pledge from Gates Foundation
The Gates Foundation pledged $100 million to support GFF's 2026–2030 strategy focused on ending preventable deaths among women, children, and adolescents in low- and middle-income countries, strengthening health systems through catalytic financing and partnerships.
Promising New Cancer Drugs in Development Transform Treatment Landscape
Several innovative cancer therapies show promise in 2025, including Darovasertib for uveal melanoma aiming to preserve vision, agenT-797 for checkpoint-resistant solid tumors, and Iza-bren ADCs for diverse epithelial cancers, with multiple trials showing durable clinical benefits.
Phase 3 Trial Demonstrates Effective Therapy for Aggressive Brain Cancer
The STELLAR trial by Orbus Therapeutics revealed a combination of eflornithine and lomustine significantly benefits patients with glioblastoma by targeting tumor cell proliferation, showing promising survival improvements.
CRISPR-Based Gene-Editing Inhalation Therapy Advances Preclinical Models
New gene-editing therapy delivered via inhalation nanoparticle technology shows efficacy in preclinical studies, highlighting next steps toward treating lung-related genetic diseases with precision medicine approaches.
NCI Renews Major Grant for Cancer Center to Accelerate Clinical Trials
The National Cancer Institute renewed funding to support Wistar and ChristianaCare's cancer center, enabling translation of cancer discoveries into early-phase clinical trials targeting pancreatic, melanoma, lung, and other cancers.
Experimental Drug TY1 Enhances DNA Repair and Tissue Regeneration
Cedars-Sinai researchers developed TY1, an experimental drug that promotes repair of damaged DNA and accelerates tissue healing, presenting a novel approach to treat injury and degenerative diseases.
Antibody Therapy Shows Potential Against Triple Negative Breast Cancer in Models
Preclinical studies at MUSC Hollings Cancer Center demonstrate a new antibody that interrupts survival, growth, and immune evasion mechanisms in triple-negative breast cancer cells, paving the way for new treatment possibilities.
WHO-Collaborating Centers and Western Pacific Region Tackle Climate and Health Crisis
Western Pacific countries endorse enhanced emergency coordination mechanisms and WHO introduces an ambitious blueprint addressing the health impacts of the climate crisis and resurgence of HIV, emphasizing multi-sectoral action and youth engagement.